Mandana Khalili, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Ave, SFGH 5
San Francisco CA 94110
Phone628-206-4766
ORCID ORCID Icon0000-0001-9178-9139 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UCSFMentor Development Program Certificate2007Research Mentoring
    UCSFM.A.S2005Masters in Advanced Studies in Clinical and Epidemiologic Research
    UCSFTransplant Hepatology 1999Transplant Hepatology and Post-Doctoral Research
    Ochsner Clinic Hepatology1998Hepatology
    McGill UniversityGastroenterology1997Gastroenterology
    University of OttawaM.D.1992Medicine
    Collapse Awards and Honors
    Peking Union Medical College, Beijing, China2019Visiting Professor, Department of Scientific Research
    Peking Union Medical College, Beijing, China2018Certificate of Appreciation-Mentor Training Program
    UCSF2017Harold L. Luft Award, Health Disparity Mentoring Award Nomination
    UCSF2016ZSFG Distinction in Medical Education Award Nomination
    UCSF2015Academic Senate Distinction in Mentoring Award Nomination
    NIH2014Mid-Career Investigator Award in Patient Oriented Research
    UCSF2013Academic Senate Distinction in Mentoring Award Nomination
    UCSF2009UCSF University Community Partnerships Council Service Learning Award
    UCSF2008Longitudinal Clinical Experience Appreciation Certificate
    Schering Oncology2001Recognizing Discovery and Innovation in 2001: Milestones in Hepatitis C, Hepatitis Innovation Award
    Gastroenterology Research Group2000American Digestive Health Foundation, Martin Brotman Training and Transition Award
    Canada1988Natural Sciences and Engineering Research Council Award
    McGill University1986J.W. McConnell Entrance Award

    Collapse Overview 
    Collapse Overview
    POSITIONS:
    Chief of Clinical Hepatology, San Francisco General Hospital
    Co-Director, Clinical and Translational Science Institute (CTSI)-Comprehensive Mentoring Program
    Unit Director, CTSI- Mentor Consultation Services

    RESEARCH PROGRAM:
    My research focuses on natural history of chronic viral hepatitis (hepatitis B and hepatitis C), Alcohol-induced liver injury and pathogenesis of alcoholic and non-alcoholic fatty liver disease, novel treatments for viral hepatitis and fatty liver disease, health services/health disparity in liver disease, and evaluation of metabolic abnormalities within the context of alcohol-related liver disease, fatty liver disease and viral hepatitis (with and without HIV coinfection). My group previously evaluated mechanisms of insulin resistance and secretion in a large cohort of hepatitis C infected patients and Latinos with and without HCV infection, and is now examining how alcohol affects insulin action among the high risk populations. We are studying insulin action in adipose tissue, muscle and liver over time, using direct measures of insulin secretion and insulin action. We are also studying the mechanisms of immune response and influence of microbiome dysbiosis on metabolic parameters. We have evaluated impact of coexisting nonalcoholic and alcoholic fatty liver disease on chronic hepatitis B infection. As one of clinical centers of the large NIH-funded Hepatitis B Research Network, we are evaluating the natural history of chronic hepatitis B infection and optimal hepatitis B management in several prospective cohorts. Through our community and participatory research at Zucherberg San Francisco General Hospital we evaluate hepatitis B screening, management and liver cancer screening practices in hepatitis B-infected underserved populations including the impact of liver cancer screening on mortality. Our focus on health services and implementation science research involves evaluation of the impact of educational interventions on patient and provider knowledge, attitudes, and barriers to hepatitis C, hepatitis B, and fatty liver care as well as primary care-specialist care coordination and access to care for viral hepatitis and nonalcoholic and alcoholic fatty liver disease. In addition, we have implemented an infrastructure for hepatitis C screening and treatment within homeless shelters in San Francisco and nationally and continue to evaluate best practices in scaling up hepatitis C management in persons who inject drugs and homeless residents.

    WEBSITES
    http://ctsi.ucsf.edu/about-us/team/programs/career-development-cd
    http://accelerate.ucsf.edu/training/mdp-people
    http://livercenter.ucsf.edu/members/mkhalili.html
    http://ctsi.ucsf.edu/news/about-ctsi/driving-excellence-mentoring-ucsf
    Collapse In The News

    Collapse Research 
    Collapse Research Activities and Funding
    Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systems
    NIH R01AA029312Jun 1, 2021 - Feb 28, 2026
    Role: Principal Investigator
    Alcohol's impact on immunological and virological profiles in HIV patients
    NIH/NIAAA UH3AA026218Sep 20, 2019 - Aug 31, 2022
    Role: Co-Investigator
    Mentoring Multidisciplinary Patient-Oriented Research in Liver Disease
    NIH/NIAAA K24AA022523May 1, 2019 - Apr 30, 2024
    Role: Principal investigator
    Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
    NIH U01DK082944Aug 31, 2015 - May 31, 2022
    Role: Principal Investigator
    HBV-HIV Coinfection Research Network
    NIH/NIDDK R01 DK 094818Sep 23, 2013 - Aug 31, 2019
    Role: Co-Investigator, UCSF Site PI
    Mentoring Multidisciplinary Patient-Oriented Research in Liver Disease
    NIH K24AA022523Aug 1, 2013 - Apr 30, 2024
    Role: Principal Investigator
    Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos
    NIH R01DK074673Apr 1, 2008 - Feb 28, 2015
    Role: Principal Investigator
    HCV-induced alterations in glucose metabolism
    NIH R03DK071531Aug 15, 2005 - Jul 31, 2009
    Role: Principal Investigator
    Insulin Resistance in HCV Infection
    NIH K23DK062013Aug 1, 2002 - Jun 30, 2007
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Global Health
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study. J Viral Hepat. 2021 Aug 06. Lee WM, King WC, Janssen HLA, Ghany MG, Fontana RJ, Fried M, Sterling RK, Feld JJ, Wang J, Mogul DB, Cooper SL, Bisceglie AMD, Hepatitis B Research Network (HBRN) . PMID: 34355475.
      View in: PubMed   Mentions:    Fields:    
    2. A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study. Hepatology. 2021 Jul 13. Sulkowski MS, Moon JS, Sherman KE, Morelli G, Darling JM, Muir AJ, Khalili M, Fishbein DA, Hinestrosa F, Shiffman ML, Di Bisceglie A, Rajender Reddy K, Pearlman B, Lok AS, Fried MW, Stewart PW, Peter J, Wadsworth S, Kixmiller S, Sloan A, Vainorius M, Horne PM, Michael L, Dong M, Evon DM, Segal JB, Nelson DR, PRIORITIZE Study Team . PMID: 34255381.
      View in: PubMed   Mentions:    Fields:    
    3. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America. Hepatology. 2021 Jun 16. Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RK. PMID: 34133774.
      View in: PubMed   Mentions:    Fields:    
    4. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy. Hepatology. 2021 Jun; 73(6):2124-2140. Lok AS, Perrillo R, Lalama CM, Fried MW, Belle SH, Ghany MG, Khalili M, Fontana RJ, Sterling RK, Terrault N, Feld JJ, Di Bisceglie AM, Lau DTY, Hassan M, Janssen HLA, Hepatitis B Research Network (HBRN) . PMID: 32936969.
      View in: PubMed   Mentions: 1     Fields:    
    5. Patient-reported experiences with direct acting antiviral therapy in an integrated model of hepatitis C care in homeless shelters. J Viral Hepat. 2021 May 18. Kim S, Powell J, Naugle J, Ricco M, Magee C, Masson C, Zevin B, Bush D, Khalili M. PMID: 34003525.
      View in: PubMed   Mentions:    Fields:    
    6. Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B. GastroHep. 2021 May; 3(3):196-208. Evon DM, Lin HS, Fontana RJ, Khalili M, Yim C, Wahed AS, Hoofnagle JH. PMID: 34421369.
      View in: PubMed   Mentions:
    7. Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America. J Viral Hepat. 2021 Jul; 28(7):1042-1056. Cooper SL, King WC, Mogul DB, Ghany MG, Schwarz KB, Hepatitis B Research Network (HBRN) . PMID: 33893706.
      View in: PubMed   Mentions:    Fields:    
    8. Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes. Hepatology. 2021 May; 73(5):1637-1651. Lau DTY, Ganova-Raeva L, Wang J, Mogul D, Chung RT, Lisker-Melman M, Chang KM, Shaikh OS, Janssen HLA, Wahed AS, Lok AS, Hepatitis B Research Network . PMID: 32860463.
      View in: PubMed   Mentions:    Fields:    
    9. Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver. JCI Insight. 2021 04 08; 6(7). Traum D, Wang YJ, Schwarz KB, Schug J, Wong DK, Janssen H, Terrault NA, Khalili M, Wahed AS, Murray KF, Rosenthal P, Ling SC, Rodriguez-Baez N, Sterling RK, Lau DT, Block TM, Feldman MD, Furth EE, Lee WM, Kleiner DE, Lok AS, Kaestner KH, Chang KM. PMID: 33621209.
      View in: PubMed   Mentions: 1     Fields:    
    10. Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B. Am J Gastroenterol. 2021 Apr 08. Khalili M, Kleiner DE, King WC, Sterling RK, Ghany MG, Chung RT, Bhan AK, Rosenthal P, Lisker-Melman M, Ramachandran R, Lok AS, ; and the Hepatitis B Research Network (HBRN) . PMID: 33840726.
      View in: PubMed   Mentions:    Fields:    
    11. A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America. Hepatology. 2021 Mar 20. Sterling RK, King WC, Khalili M, Chung RT, Sulkowski M, Jain MK, Lisker-Melman M, Ghany MG, Wong DK, Hinerman AS, Bhan AK, Wahed AS, Kleiner DE, HBV-HIV Cohort Study of the Hepatitis B Research Network . PMID: 33743541.
      View in: PubMed   Mentions: 1     Fields:    
    12. Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults. Dig Dis Sci. 2021 Feb 08. Sterling RK, King WC, Khalili M, Kleiner DE, Hinerman AS, Sulkowski M, Chung RT, Jain MK, Lisker-Melman MA, Wong DK, Ghany MG, HBV-HIV Cohort Study of the Hepatitis B Research Network . PMID: 33559089.
      View in: PubMed   Mentions: 1     Fields:    
    13. Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017. Am J Gastroenterol. 2021 02 01; 116(2):401-406. Wong RJ, Saab S, Konyn P, Sundaram V, Khalili M. PMID: 32976121.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Reply. Hepatol Commun. 2020 Dec; 4(12):1880. Powell J, Khalili M. PMID: 33305157.
      View in: PubMed   Mentions:
    15. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States. Clin Gastroenterol Hepatol. 2020 Sep 12. Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich NE, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami P, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, Duarte-Rojo A, Lindenmeyer CC, Frenette C, Ge J, Mehta N, Yao F, Benhammou JN, Bloom PP, Leise M, Kim HS, Levy C, Barnard A, Khalili M, Ioannou GN. PMID: 32927050.
      View in: PubMed   Mentions:    Fields:    
    16. Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection. Clin Infect Dis. 2020 Sep 01. Khalili M, King WC, Kleiner DE, Jain MK, Chung RT, Sulkowski M, Lisker-Melman M, Wong DK, Ghany M, Sanyal A, Sterling RK, HIV-HBV Cohort Study of the Hepatitis B Research Network . PMID: 32869840.
      View in: PubMed   Mentions:    Fields:    
    17. A Patient-Centered Hepatitis B Virus (HBV) Educational Intervention Improves HBV Care Among Underserved Safety-Net Populations. J Clin Gastroenterol. 2020 08; 54(7):642-647. Wong RJ, Khalili M. PMID: 31688365.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    18. Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts. Liver Int. 2020 08; 40(8):1841-1852. Mangia A, Milligan S, Khalili M, Fagiuoli S, Shafran SD, Carrat F, Ouzan D, Papatheodoridis G, Ramji A, Borgia SM, Wedemeyer H, Losappio R, Pérez-Hernandez F, Wick N, Brown RS, Lampertico P, Doucette K, Ntalla I, Ramroth H, Mertens M, Vanstraelen K, Turnes J. PMID: 32449966.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    19. Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters. BMC Infect Dis. 2020 May 29; 20(1):386. Masson CL, Fokuo JK, Anderson A, Powell J, Zevin B, Bush D, Khalili M. PMID: 32471376.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    20. Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B. Ann Hepatol. 2020 Jul - Aug; 19(4):388-395. Lisker-Melman M, Khalili M, Belle SH, Terrault NA, Lin HS, Smith CI, Chung RT, Tsai N, Bzowej NH, Tran TT, Schwarzenberg SJ, Hepatitis B Research Network (HBRN) . PMID: 32507734.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey. Dig Dis Sci. 2021 02; 66(2):434-441. Mukhtar NA, Evon DM, Yim C, Lok AS, Lisha N, Lisker-Melman M, Hassan M, Janssen HLA, Khalili M. PMID: 32239377.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective. Hepatol Commun. 2020 May; 4(5):646-656. Fokuo JK, Masson CL, Anderson A, Powell J, Bush D, Ricco M, Zevin B, Ayala C, Khalili M. PMID: 32363316.
      View in: PubMed   Mentions:
    23. Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America. Ann Hepatol. 2020 Jul - Aug; 19(4):437-445. Brahmania M, Liu S, Wahed AS, Yim C, Hansen BE, Khalili M, Terrault NA, Lok AS, Ghany M, Wang J, Wong D, Janssen HLA, Hepatitis B Research Network . PMID: 32139262.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis. Aliment Pharmacol Ther. 2020 02; 51(4):457-468. Evon DM, Lin HS, Khalili M, Fontana RJ, Yim C, Wahed AS, Fried MW, Hoofnagle JH, Hepatitis B Research Network (HBRN) . PMID: 31943262.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2019 12 14; 394(10215):2184-2196. Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ, REGENERATE Study Investigators . PMID: 31813633.
      View in: PubMed   Mentions: 137     Fields:    Translation:HumansCTClinical Trials
    26. Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia. Am J Gastroenterol. 2019 11; 114(11):1753-1763. Zhou K, Wahed AS, Cooper S, Di Bisceglie AM, Fontana RJ, Ghany MG, Khalili M, Lok AS, Perrillo R, Lee WM, Lau DTY, Sterling R, Janssen HLA, Terrault NA. PMID: 31658127.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    27. Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults. Hepatology. 2020 02; 71(2):411-421. Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG, HIV-HBV Cohort Study of the Hepatitis B Research Network . PMID: 31220357.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study. Am J Gastroenterol. 2019 08; 114(8):1283-1291. Bzowej NH, Tran TT, Li R, Belle SH, Smith CI, Khalili M, Chung R, Tsai N, Terrault N, Hepatitis B Research Network (HBRN) . PMID: 31082876.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Hepatitis C Screening in an Underserved U.S. Cohort of Reproductive Age Women. Hepatol Commun. 2019 Sep; 3(9):1183-1190. Kim NJ, Holguin D, Bush D, Khalili M. PMID: 31497740.
      View in: PubMed   Mentions:
    30. Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B. J Viral Hepat. 2019 07; 26(7):856-865. Di Bisceglie AM, King WC, Lisker-Melman M, Khalili M, Belle SH, Feld JJ, Ghany MG, Janssen HLA, Lau D, Lee WM, Ling SC, Cooper S, Rosenthal P, Schwarz KB, Sterling RK, Teckman JH, Terrault N, Hepatitis B Research Network (HBRN) . PMID: 30974509.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    31. Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study. Am J Gastroenterol. 2019 05; 114(5):746-757. Sterling RK, Wahed AS, King WC, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG, HIV-HBV Cohort Study of the Hepatitis B Research Network . PMID: 30410040.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    32. Distinct phenotype and function of circulating Vd1+ and Vd2+ ?dT-cells in acute and chronic hepatitis B. PLoS Pathog. 2019 04; 15(4):e1007715. Chang KM, Traum D, Park JJ, Ho S, Ojiro K, Wong DK, Wahed AS, Terrault NA, Khalili M, Sterling RK, Janssen HLA, Shuhart MC, Lau DT, Roberts LR, Johnson GS, Kaplan DE, Betts MR, Lee WM, Lok ASF, Hepatitis B Research Network (HBRN) . PMID: 30998783.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    33. Prevalence and Impact of Hepatitis E Virus Infection Among Persons With Chronic Hepatitis B Living in the US and Canada. Open Forum Infect Dis. 2019 May; 6(5):ofz175. McGivern DR, Lin HS, Wang J, Benzine T, Janssen HLA, Khalili M, Lisker-Melman M, Fontana RJ, Belle SH, Fried MW. PMID: 31139669.
      View in: PubMed   Mentions:
    34. Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection. Hepatology. 2019 06; 69(6):2338-2348. Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS, Hepatitis B Research Network . PMID: 30549279.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    35. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection. Clin Gastroenterol Hepatol. 2019 11; 17(12):2541-2551.e2. Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA, Hepatitis B Research Network . PMID: 30743006.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    36. HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition. Clin Gastroenterol Hepatol. 2020 01; 18(1):259-261. Brouwer WP, Zhao Q, Hansen BE, Lau D, Khalili M, Terrault NA, Di Bisceglie AM, Perrillo RP, Fried MW, Wong D, Feld JJ, Belle SH, Janssen HLA, Hepatitis B Research Network . PMID: 30630104.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    37. Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net. Dig Dis Sci. 2018 12; 63(12):3250-3252. Khalili M, Wong RJ. PMID: 30311153.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    38. Liver Disease Monitoring Practices After Hepatitis C Cure in the Underserved Population. Hepatol Commun. 2018 Oct; 2(10):1274-1283. Kim NJ, Magee C, Cummings C, Park H, Khalili M. PMID: 30288480.
      View in: PubMed   Mentions:
    39. Race and Hepatitis C Care Continuum in an Underserved Birth Cohort. J Gen Intern Med. 2019 10; 34(10):2005-2013. Kim NJ, Locke CJ, Park H, Magee C, Bacchetti P, Khalili M. PMID: 30238404.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsPHPublic Health
    40. Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved. Autoimmunity. 2018 08; 51(5):258-264. Lee B, Holt EW, Wong RJ, Sewell JL, Somsouk M, Khalili M, Maher JJ, Tana MM. PMID: 29890851.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans. Ann Hepatol. 2018 May-June; 17(3):413-418. Beck KR, Kim NJ, Khalili M. PMID: 29735789.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    42. Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B. Diabetes Care. 2018 06; 41(6):1251-1259. Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok AS, Hepatitis B Research Network (HBRN) , Harvard Consortium . PMID: 29599296.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    43. Impact of Moderate Alcohol Discontinuation on Insulin Action and Secretion in Latinos With and Without Hepatitis C. Alcohol Clin Exp Res. 2018 Mar; 42(3):492-499. Uribe LA, Bacchetti P, Gelman N, Burchard E, Fitch M, Hellerstein M, Khalili M. PMID: 29220547.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans. Am J Gastroenterol. 2018 02; 113(2):243-253. Wen JW, Kohn MA, Wong R, Somsouk M, Khalili M, Maher J, Tana MM. PMID: 29380822.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    45. Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success. J Immunol. 2018 02 01; 200(3):1124-1132. Méndez-Lagares G, Lu D, Chen C, Terrault N, Segal MR, Khalili M, Monto A, Shen H, Manos MM, Lanier LL, Ryan JC, McCune JM, Hartigan-O'Connor DJ. PMID: 29263212.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    46. Provider, Patient, and Practice Factors Shape Hepatitis B Prevention and Management by Primary Care Providers. J Clin Gastroenterol. 2017 Aug; 51(7):626-631. Mukhtar NA, Kathpalia P, Hilton JF, Lau G, Yu A, Grumbach K, Nguyen TT, Chan D, Khalili M. PMID: 27811627.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    47. Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment. J Viral Hepat. 2017 11; 24(11):1032-1042. Lok AS, Ganova-Raeva L, Cloonan Y, Punkova L, Lin HS, Lee WM, Ghany MG, Hepatitis B Research Network (HBRN) . PMID: 28581155.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    48. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. N Engl J Med. 2017 06 01; 376(22):2134-2146. Bourlière M, Gordon SC, Flamm SL, Cooper CL, Ramji A, Tong M, Ravendhran N, Vierling JM, Tran TT, Pianko S, Bansal MB, de Lédinghen V, Hyland RH, Stamm LM, Dvory-Sobol H, Svarovskaia E, Zhang J, Huang KC, Subramanian GM, Brainard DM, McHutchison JG, Verna EC, Buggisch P, Landis CS, Younes ZH, Curry MP, Strasser SI, Schiff ER, Reddy KR, Manns MP, Kowdley KV, Zeuzem S, POLARIS-1 and POLARIS-4 Investigators . PMID: 28564569.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansCellsCTClinical Trials
    49. Determination of hepatitis B phenotype using biochemical and serological markers. J Viral Hepat. 2017 04; 24(4):320-329. Di Bisceglie AM, Lombardero M, Teckman J, Roberts L, Janssen HL, Belle SH, Hoofnagle JH, Hepatitis B Research Network (HBRN) . PMID: 27917600.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    50. Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience. Dig Dis Sci. 2016 12; 61(12):3602-3608. Beck KR, Kim N, Khalili M. PMID: 27743164.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    51. Moderate Alcohol Use and Insulin Action in Chronic Hepatitis C Infection. Dig Dis Sci. 2016 08; 61(8):2417-2425. Burman BE, Bacchetti P, Khalili M. PMID: 27007134.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Hepatitis C Screening Rate Among Underserved Adults With Serious Mental Illness Receiving Care in California Community Mental Health Centers. Am J Public Health. 2016 Apr; 106(4):740-2. Trager E, Khalili M, Masson CL, Vittinghoff E, Creasman J, Mangurian C. PMID: 26890183.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    53. Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). Dig Dis Sci. 2016 Apr; 61(4):1186-96. Evon DM, Wahed AS, Johnson G, Khalili M, Lisker-Melman M, Fontana RJ, Sarkar S, Reeve BB, Hoofnagle JH. PMID: 26831489.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    54. Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. Gastroenterology. 2016 Mar; 150(3):684-695.e5. Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM, Hepatitis B Research Network . PMID: 26684441.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    55. Impact of gender and menopausal status on metabolic parameters in chronic hepatitis C infection. J Viral Hepat. 2016 Mar; 23(3):232-9. Gonzales CA, Bacchetti P, Khalili M. PMID: 26554398.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. Is there a relationship between hepatitis B surface antibody status and diabetes? J Diabetes. 2016 Jan; 8(1):36-7. Khalili M, Sanyal A. PMID: 26201556.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. Diabetes and prediabetes in patients with hepatitis B residing in North America. Hepatology. 2015 Nov; 62(5):1364-74. Khalili M, Lombardero M, Chung RT, Terrault NA, Ghany MG, Kim WR, Lau D, Lisker-Melman M, Sanyal A, Lok AS, HBRN . PMID: 26390278.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    58. Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics. Ann Hepatol. 2015 Mar-Apr; 14(2):234-42. Schaeffer S, Khalili M. PMID: 25671833.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    59. The birth and potential death of IL28B genotyping for hepatitis C therapy. Per Med. 2015 Mar; 12(2):55-57. Wu AH, Khalili M. PMID: 29754535.
      View in: PubMed   Mentions: 1     Fields:    
    60. Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data. J Gen Intern Med. 2015 Jan; 30(1):68-74. Mukhtar NA, Toy BC, Burman BE, Yu A, Chen AH, Berman P, Nguyen T, Chan D, Hammer H, McCulloch CE, Khalili M. PMID: 25324148.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    61. Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection. Liver Int. 2015 Jan; 35(1):101-7. Burman BE, Bacchetti P, Ayala CE, Gelman N, Melgar J, Khalili M. PMID: 25156890.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    62. Depression is not associated with peripheral insulin resistance in patients with chronic hepatitis C infection. J Viral Hepat. 2015 Mar; 22(3):272-80. Shah SC, Kornak J, Khalili M. PMID: 25196736.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    63. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):183-92. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS, Hepatitis B Research Network , Hepatitis B Research Network . PMID: 25010003.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    64. Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis. J Subst Abuse Treat. 2014 Apr; 46(4):528-31. Larios SE, Masson CL, Shopshire MS, Hettema J, Jordan AE, McKnight C, Young C, Khalili M, Seewald RM, Min A, Hengl N, Sorensen JL, Des Jarlais DC, Perlman DC. PMID: 24462241.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    65. Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care. Dig Dis Sci. 2014 Jan; 59(1):46-56. Burman BE, Mukhtar NA, Toy BC, Nguyen TT, Chen AH, Yu A, Berman P, Hammer H, Chan D, McCulloch CE, Khalili M. PMID: 24052195.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    66. A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. Am J Public Health. 2013 Oct; 103(10):e81-8. Masson CL, Delucchi KL, McKnight C, Hettema J, Khalili M, Min A, Jordan AE, Pepper N, Hall J, Hengl NS, Young C, Shopshire MS, Manuel JK, Coffin L, Hammer H, Shapiro B, Seewald RM, Bodenheimer HC, Sorensen JL, Des Jarlais DC, Perlman DC. PMID: 23947319.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansPHPublic Health
    67. Hepatocellular screening in hepatitis-B infected Asian Americans. J Viral Hepat. 2013 Jul; 20(7):515-6. Khalili M, Stewart S. PMID: 23730847.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response. Liver Int. 2013 Aug; 33(7):999-1007. Lubega S, Agbim U, Surjadi M, Mahoney M, Khalili M. PMID: 23509897.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    69. Insulin sensitivity and variability in hepatitis C virus infection using direct measurement. Dig Dis Sci. 2013 Apr; 58(4):1141-8. Mukhtar NA, Bacchetti P, Ayala CE, Melgar J, Christensen S, Maher JJ, Khalili M. PMID: 23086116.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    70. A mentor development program for clinical translational science faculty leads to sustained, improved confidence in mentoring skills. Clin Transl Sci. 2012 Aug; 5(4):362-7. Feldman MD, Steinauer JE, Khalili M, Huang L, Kahn JS, Lee KA, Creasman J, Brown JS. PMID: 22883616.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    71. Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. Diabetes Care. 2012 May; 35(5):1090-4. Brandman D, Bacchetti P, Ayala CE, Maher JJ, Khalili M. PMID: 22399695.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    72. Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans. J Viral Hepat. 2012 Aug; 19(8):594-600. Sarkar M, Stewart S, Yu A, Chen MS, Nguyen TT, Khalili M. PMID: 22762144.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    73. Assessment of factors associated with pre-diabetes in HCV infection including direct and dynamic measurements of insulin action. J Viral Hepat. 2012 Jul; 19(7):480-7. Mukhtar NA, Ayala C, Maher JJ, Khalili M. PMID: 22676360.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    74. Racial differences in hepatitis C treatment eligibility. Hepatology. 2011 Jul; 54(1):70-8. Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Noviello S, Brass CA, Albrecht JK, McHutchison JG, Sulkowski MS, IDEAL Study Team . PMID: 21488082.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    75. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Dig Dis Sci. 2011 May; 56(5):1516-23. Khalili M, Guy J, Yu A, Li A, Diamond-Smith N, Stewart S, Chen M, Nguyen T. PMID: 21046247.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    76. Formal patient education improves patient knowledge of hepatitis C in vulnerable populations. Dig Dis Sci. 2011 Jan; 56(1):213-9. Surjadi M, Torruellas C, Ayala C, Yee HF, Khalili M. PMID: 20972850.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    77. Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate. Gastroenterology. 2010 Nov; 139(5):1602-11, 1611.e1. Sulkowski MS, Shiffman ML, Afdhal NH, Reddy KR, McCone J, Lee WM, Herrine SK, Harrison SA, Poordad FF, Koury K, Deng W, Noviello S, Pedicone LD, Brass CA, Albrecht JK, McHutchison JG, IDEAL Study Team . PMID: 20723545.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    78. Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity. Hepatology. 2010 Jul; 52(1):38-46. Lam KD, Bacchetti P, Abbasi F, Ayala CE, Loeb SM, Shah V, Wen MJ, Reaven GM, Maher JJ, Khalili M. PMID: 20578127.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    79. A glimpse of future hepatitis C virus treatment paradigms. Hepatology. 2010 Feb; 51(2):707-10. Terrault N, Khalili M. PMID: 20104511.
      View in: PubMed   Mentions: 1     Fields:    
    80. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med. 2009 Aug 06; 361(6):580-93. McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS, IDEAL Study Team . PMID: 19625712.
      View in: PubMed   Mentions: 321     Fields:    Translation:HumansCells
    81. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection. Liver Transpl. 2008 Oct; 14(10):1491-7. Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA. PMID: 18825708.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    82. Coinfection with Hepatitis Viruses and HIV Update. In: Peiperl L, Volberding PA, eds. HIV InSite Knowledge Base [textbook on-line]. 2006. Khalili M. .
    83. Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years. Clin Transplant. 2006 Jan-Feb; 20(1):1-9. Khalili M, Vardanian AJ, Hamerski CM, Wang R, Bacchetti P, Roberts JP, Terrault NA. PMID: 16556146.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial. Dig Dis Sci. 2005 Jun; 50(6):1148-55. Khalili M, Bernstein D, Lentz E, Barylski C, Hoffman-Terry M. PMID: 15986873.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    85. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant. 2005 Jan; 5(1):118-24. Shergill AK, Khalili M, Straley S, Bollinger K, Roberts JP, Ascher NA, Terrault NA. PMID: 15636619.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    86. Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients. HIV Clin Trials. 2004 Nov-Dec; 5(6):383-91. Beatty G, Chu J, Kulkarni K, Lipshutz G, Khalili M, Abbasi F, Stansell J, Reaven GM. PMID: 15682351.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    87. Treatment of the hepatitis C virus in patients coinfected with HIV. Gastroenterol Clin North Am. 2004 Sep; 33(3):479-96, vii-viii. Khalili M, Proietti N. PMID: 15324939.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    88. Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial. . 2004 Apr 15; 35(5):464-72. Sulkowski MS, Felizarta F, Smith C, Slim J, Berggren R, Goodman R, Ball L, Khalili M, Dieterich DT, Hepatitis Resource Network Clinical Trials Group . PMID: 15021311.
      View in: PubMed   Mentions:
    89. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl. 2004 Mar; 10(3):349-55. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. PMID: 15004760.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    90. Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients. Metabolism. 2003 Jul; 52(7):858-61. Chu JW, Abbasi F, Beatty GW, Khalili M, Koch J, Rosen A, Schmidt JM, Stansell JD, Reaven GM. PMID: 12870161.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    91. Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors. . 2003 May 01; 33(1):34-40. Beatty G, Khalili M, Abbasi F, Chu J, Reaven GM, Rosen A, Schmidt JM, Stansell J, Koch J. PMID: 12792353.
      View in: PubMed   Mentions:
    92. Peiperl L, Volberding PA, eds. HIV InSite Knowledge Base [textbook on-line]. Coinfection with Hepatitis Viruses and HIV Update. 2003; Available from: HIV InSite. Khalili M. .
    93. Hepatitis C in the setting of HIV co-infection. Microbes Infect. 2002 Oct; 4(12):1247-51. Khalili M, Behm BW. PMID: 12467766.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    94. Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C. Am J Gastroenterol. 2000 May; 95(5):1284-9. Khalili M, Denham C, Perrillo R. PMID: 10811340.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    95. Interferon Therapy of Hepatitis B. Clin Liver Dis. 1999; 3(2):363-87. Khalili M, Perrillo RP.
    96. Ionescu-Shiley valve failure. I: Experience with 125 standard-profile explants. Ann Thorac Surg. 1992 Jul; 54(1):111-6. Walley VM, Keon CA, Khalili M, Moher D, Campagna M, Keon WJ. PMID: 1610221.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    97. Ionescu-Shiley valve failure. II: Experience with 25 low-profile explants. Ann Thorac Surg. 1992 Jul; 54(1):117-22; discussion 122-3. Walley VM, Keon CA, Khalili M, Moher D, Campagna M, Keon WJ. PMID: 1610222.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    98. The University of Ottawa Heart Institute Cardiac Transplant Program: the first 100 transplants. A pathologic study of the explanted hearts. Mod Pathol. 1992 Mar; 5(2):158-64. Wolfsohn AL, Walley VM, Davies RA, Keon CA, Khalili M, Keon WJ. PMID: 1574494.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Mandana's Networks
    Concepts (305)
    Derived automatically from this person's publications.
    _
    Co-Authors (64)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _